Föreskrifter (HSLF-FS 2023:34) om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika

Senast ändrade genom HSLF-FS 2023:6. 1

HSLF-FS – – –

– – –

2023:34 g

– – –

in

– – –

kn

– – – är – – –

m

– – – An – – –

– – – – – – ll – – – ne ng – – – ni – I I – I I –

tio

ck – – – – – na – P I P I – P I P I – te – – –

er

för – – –

Int

– – – – – – ng – – – sk ni – – – – I I I – I I I – I I I

en ck

Sv te – – –

– – –

för

– – – – – – – – – – – – – – – – – – n – – –

– – –

am

– – –

t n

– – – isk – – –

em – – – golin-8-karboxamid – – – gt k – – – di – – – ty – – –

En – – – – – – – – – ne – – – m – – – Ä – 3-(2-[etyl(metyl)amino]etyl)-1H-indol-4-ylacetat N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-butyl- 1H-indazol-3-karboxamid N-(1-amino-3,3-dimetyl-1-oxobutan- 2-yl)-1-(cyklohexylmetyl)-1H-indazol-3- karboxamid – 1-fenyl-2-(pyrrolidin-1yl)hexan-1-on 1-fenyl-4-metyl-2-(pyrrolidin-1-yl)pentan-1-on 1-(3-fluorofenyl)-4-metyl-2-(pyrrolidin-1-yl) pentan-1-on – 4-jodo-2,5-dimetoxifenetylamin 1-(cyklopropankarbonyl)-N,N-dietyl-6- metyl-9,10-didehydroer 2,5-dimetoxi-4-propylfenetylamin

– – – t e – – –

lig – – –

and

n – – –

an m

m – – – ra v na – – –

kom

nd – – –

re

A – – –

fö

– 4-AcO-MET ADB-BUTINACA ADB-CHMINACA MAB-CHMINACA – Alfa-PHP Alfa-PiHP 3F-alfa-PiHP – 2C-I 1cP-LSD 2C-P

– – – ng – – – ni – – –

– – –

äm

– – – – – –

-ben

N – – – – – –

IN

2 – – –

– – – – – –

g

– – –

in

– – –

kn

– – – är – – –

m

– – – An – – –

– – – – – – ll – – – ne ng – – – ni – – – tio V ck – – – P I na – P I – N I – N I N I te – – –

er

för – – –

Int

– – – – – – ng – – – sk ni – – – – I I – I I I – II I en ck IV Sv te – – –

– – –

för

– – – – – – – – – – – – – – – – – – n – – – – – –

am

– – – t n golin-8-karboxamid – – – isk – – – em – – – – – – gt k – – – di – – – ty – – –

En – – – – – – – – – ne – – – m – – – Ä – 7-kloro-5-(o-klorofenyl)-1,3-dihydro-2H-1,4- bensodiazepin-2-on 2-(etylamino)-2-(3-metylfenyl)cyklohexan-1-on 2-etyl-4-fenyl-9-metyl-6H-[tieno3,2-f][1,2,4] triazolo[4,3-a][1,4]diazepin – 3-(2-etylfenyl)-2-metylkinazolin-4(3H)-on 2-[2-(4-etoxibensyl)-1H-benso[d] imidazol-1-yl]-N,N-dietyletanamin N,N,6-trietyl-9,10-didehydroer – 1-dietylaminoetyl-2-p-etoxybensyl-5- nitrobensimidazol 2-(4-etoxibensyl)-5-nitro-1-[2-(pyrrolidin-1-yl) etyl]-1H-benso[d]imidazol

– – – t e – – – lig – – –

and

n – – –

an m

m – – – ra v na – – –

kom

nd – – –

re

A – – –

fö

– Deoximetoxetamin DMXE Deskloretizolam – Etakvalon Etazen ETH-LAD – Etonitazepyn

– – – ng – – – ni – – – – – –

äm

– – – – – –

-ben

N – – – – – – IN Delorazepam Etonitazen – – – 3

HSLF-FS – – –

– – –

2023:34 g

– – –

in

– – –

kn

– – – är – – –

m

– – – An – – –

– – – – – – ll – – – ne ng – – – ni – – –

tio

ck – – – – – – na – – – te N I+IV – – N I+IV –

er

för – – –

Int

– – – – – – ng – – – sk ni – – – II – II I I – I I I V –

en ck

Sv te – – –

– – –

för

– – – – – – – – – – – – – – – – – – n – – – – – –

am

– – –

t n

– – – isk – – – em – – – – – – gt k – – – di – – – ty – – –

En – – – – – – – – – ne – – – m – – – Ä Tetrahydro-7α-(1-hydroxi-1-metylbutyl)-6,14- endo-etenooripavin – [1-fenyl-1-piperidyl-(2)-metyl]acetat N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]-3- fenylpropanamid 1-(4-fluorfenyl)-2-(metylamino)propan-1-on – Diacetylmorfin 3-heptyl-6a,7,8,9,10,10a-hexahydro-6,6,9-trimetyl- 6H-dibenso[b,d]pyran-1-ol 6a,7,8,9,10,10a-hexahydro-6,6,9-trimetyl-3-pentyl- 6H-dibenso[b,d]pyran-1-ol –

– – – t e – – - - – lig – – –

and

n – – –

an m

m – – – ra v na – – –

kom

nd – – –

re

A – – –

fö

– 3-fenyl- propanoylfentanyl Flefedron – Heroin Hexahydrocanna biforol HHCP Hexahydrocanna binol HHC –

– – – ng – – – ni – – – – – –

äm

– – – – – –

-ben

N – – – – – – IN Etorfin Hexapropymat 4 – – –

– – – –

g

– –

in

– –

kn

– – är – –

m

– – An – –

– – – – ll – – ne ng – – ni – –

tio

ck – – – – – – – na – N I – te – –

er

för – –

Int

– – – – ng – – sk ni – – I I I I – I I I – I

en ck

Sv te – –

– –

för

– – – – – – – – – – – – n – – – –

am

– –

t n

– – isk – – em – – – – gt k – – di – – ty on – –

En 1- – – – – – – ne – – m – – Ä 1-(3-metoxifenyl)-2-metylamino)propan-1-on 2-(isopropylamino)-2-(3-metoxifenyl) cyklohexan- 2-(3-metoxifenyl)-2-(propylamino)cyklohexan-1-on 4-metyl-1-(4-metylfenyl)-2-(pyrrolidin-1-yl)pentan- 1-on – 1-(4-fluoro-3-metylfenyl)-2-(pyrrolidin-1-yl) pentan-1-on 1-[4-(3-fenylprop-2-en-1-yl)-2-metylpiperazin-1-yl] butan-1-on N-[1-(2-fenyletyl)piperidin-4-yl]-N-(2-metylfenyl) acetamid – 1-(2-metylfenyl)-2-(metylamino)propan-1-on

– – t e – - – - - – –

lig and

n – –

an m

m – – ra v na – –

kom

nd – –

re

A – –

fö

3-metoximetka tinon Metoxisopropamin MXiPr Metoxpropamin MXPr 4-metyl-alfa-PiHP – 4F-3-metyl-alfa- PVP 2-metyl-AP-237 2-metylacetylfen tanyl – 2-MMC 2-metyl metkatinon

– – ng – – ni – – – –

äm

– – – –

-ben

N – – – –

IN

– – 5

HSLF-FS – – –

– – –

2023:34 g

– – –

in

– – –

kn

– – – är – – –

m

– – – An – – –

– – – – – – ll – – – ne ng – – – ni I – – –

tio

ck P I – – – P I P I na P I – N I – N I – te – – –

er

för – – –

Int

– – – – – – ng – – – sk ni – – – I I – II I I – I I I – I

en ck

Sv te – – –

– – –

för

– – – – – – – – – – – – – – – – – – n – – – – – –

am

– – –

t n

– – – isk – – – em – – – – – – gt k – – – di – – – ty – – –

En – – – – – – – – – ne – – – m – – – Ä 1-(3-metylfenyl)-2-(metylamino)propan-1-on 5-metoxi-α-metyl-3,4-(metylendioxy)fenetylamin – Myristylbensylmorfin N-etyl-2-[2-(4-isopropoxibensyl)-5-nitro-1H- benso[d]imidazol-1-yl]etanamin 5-(2-fluorofenyl)-1,3-dihydro-7-nitro-2H-1,4- bensodiazepin-2-on – 3,5-dimetoxi-4-propoxifenetylamin N,N-dietyl-2-[5-nitro-2-(4-propoxibensyl)-1H- benso[d]imidazol-1-yl]etanamin 3-[2-(dimetylamino)etyl]indol-4-ol – 1-[1-(2-tienyl)cyklohexyl]piperidin

– - – – t e - – - – – lig – – –

and

n – – –

an m

m – – – ra v na – – –

kom

nd – – –

re

A – – –

fö

3-MMC 3-metyl metkatinon MMDA – N-desetylisotoni tazen N-desmetylflunitra zepam – Proskalin Protonitazen Psilocin Psilotsin – TCP

– – – ng – – – ni – – – – – –

äm

– – – – – –

-ben

N – – – Tenocyklidin – – – IN Myrofin 6 – – –

– g – in –

kn – är – m –

An – – – ll – ne ng – ni –

tio

ck P I – na N I te –

er

–

för

Int –

– –

ng

–

sk ni

I I –

en ck

–

Sv te

– för –

– – – – – –

n

– am – t n – –

isk

– em –

– gt k –

di

–

ty

– En –

– – ne – m – Ä Följande isomerer och dess stereoisomerer 7,8,9,10-tetrahydro-6,6,9-trimetyl-3-pentyl-6H- dibenso[b,d]pyran-1-ol (9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimetyl-3- pentyl-6H-dibenso[b,d]pyran-1-ol (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9- trimetyl-3-pentyl-6H-dibenso[b,d]pyran-1-ol (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimetyl- 3-pentyl-6H-dibenso[b,d]pyran-1-ol 6a,7,8,9-tetrahydro-6,6,9-trimetyl-3-pentyl-6H- dibenso[b,d]pyran-1-ol (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6- dimetyl-9-metylen-3-pentyl-6H-dibenso[b,d] pyran-1-ol N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl] tetrahydrofuran-2-karboxamid –

– t e – lig –

and

an n –

m

m 1)-THC THF-F – ra v na –

kom

nd re – A fö – Tetrahydrocannabi noler delta-6a(10a)-THC delta-6a(7)-THC delta-7-THC delta-8-THC delta 10-THC delta-9(1 Tetrahydrofuran fentanyl – – ng – ni –

äm – – –

-ben

N – –

IN

– 7

HSLF-FS 2023:34 g

in kn är m An

ll ne ng ni

tio V ck – – na P I

te er för Int

ng sk ni

I I en ck IV

Sv te för

n am t n isk em

gt k di ty

En golin-8-karboxamid

ne m

Ä 5-(1-metylbutyl)-5-vinylbarbitursyra N,N-dietyl-6-metyl-1-pentanoyl-9,10- didehydroer 4-kloro-N-(l-(2-fenyletyl)-piperidin-2-yliden) bensensulfonamid

t e lig and an n m m ra v na kom nd re

-LSD -15

A fö

1V W

ng ni äm

-ben N

IN Vinylbital

____________________

Dessa föreskrifter träder i kraft den 11 juli 2023.

Läkemedelsverket JOAKIM BRANDBERG Jennie Agardh

HSLF-FS kan laddas ner via Läkemedelsverket. Webb: www.lakemedelsverket.se Författningen kan beställas via: Norstedts Juridik 106 47 Stockholm SVANENMÄRKET Telefon, kundservice: 08-657 95 00 E-post: order@forlagssystem.se 3041 0123Trycksak Internet: www.nj.se/offentligapublikationer Elanders Sverige AB, Vällingby 2023